Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-04-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.892495/full |
| _version_ | 1828839968865255424 |
|---|---|
| author | Ana Sandoval-Rodriguez Aldo Torre Juan Armendariz-Borunda Juan Armendariz-Borunda |
| author_facet | Ana Sandoval-Rodriguez Aldo Torre Juan Armendariz-Borunda Juan Armendariz-Borunda |
| author_sort | Ana Sandoval-Rodriguez |
| collection | DOAJ |
| first_indexed | 2024-12-12T19:33:51Z |
| format | Article |
| id | doaj.art-223ac9347d214a17bfd10426f64cafd8 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-12-12T19:33:51Z |
| publishDate | 2022-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-223ac9347d214a17bfd10426f64cafd82022-12-22T00:14:22ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-04-01910.3389/fmed.2022.892495892495Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological StrategiesAna Sandoval-Rodriguez0Aldo Torre1Juan Armendariz-Borunda2Juan Armendariz-Borunda3Institute of Molecular Biology in Medicine and Gene Therapy, CUCS, University of Guadalajara, Guadalajara, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoInstitute of Molecular Biology in Medicine and Gene Therapy, CUCS, University of Guadalajara, Guadalajara, MexicoTecnologico de Monterrey, School of Medicine and Health Sciences, Monterrey, Mexicohttps://www.frontiersin.org/articles/10.3389/fmed.2022.892495/fullMALFDliverNASHNAFLDsteatohepatitis |
| spellingShingle | Ana Sandoval-Rodriguez Aldo Torre Juan Armendariz-Borunda Juan Armendariz-Borunda Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies Frontiers in Medicine MALFD liver NASH NAFLD steatohepatitis |
| title | Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies |
| title_full | Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies |
| title_fullStr | Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies |
| title_full_unstemmed | Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies |
| title_short | Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies |
| title_sort | editorial liver fibrosis and mafld from molecular aspects to novel pharmacological strategies |
| topic | MALFD liver NASH NAFLD steatohepatitis |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2022.892495/full |
| work_keys_str_mv | AT anasandovalrodriguez editorialliverfibrosisandmafldfrommolecularaspectstonovelpharmacologicalstrategies AT aldotorre editorialliverfibrosisandmafldfrommolecularaspectstonovelpharmacologicalstrategies AT juanarmendarizborunda editorialliverfibrosisandmafldfrommolecularaspectstonovelpharmacologicalstrategies AT juanarmendarizborunda editorialliverfibrosisandmafldfrommolecularaspectstonovelpharmacologicalstrategies |